Green Planet Bio Engineering Co. Ltd.
Green Planet Bio Engineering Co. Ltd. is currently a public reorganized shell corporation in the United States with no active operating business. Its stated purpose is to acquire or merge with an existing business operation, and at present it generates only minimal expenses related to being a public company.
Tilikausi 2025 · muutos edellisvuodesta
Kehitys 2020–2025
Liiketoiminta
Osuus liikevaihdostaA public reorganized entity intended to acquire or merge with an operating business.
Asiakkaat
The company does not currently sell products or services to end customers because it has no active business operations. Its practical counterparties are future acquisition targets, potential investors, and the related party supporting public-company expenses. If a transaction is completed, the customer base would depend entirely on the acquired operating business.
Operating businesses that may combine with the shell to access a public listing.
Capital providers expected to fund the next business opportunity or transaction.
Global Funds, the majority stockholder, currently funds public-company expenses.
Strategia
The company’s current strategy is to identify funding and complete a business combination with an operating company. Management emphasizes that execution depends on finding suitable opportunities and securing capital from future investors or the related-party sponsor. Until that happens, the company remains a shell with no operating business.
The company has no operating business and needs a transaction to create value.
Cash needs are currently met by a majority stockholder and future plans require capital.
Maantiede
The company is based in the United States and files as a U.S. public company. No operating geography or revenue mix is disclosed because it has no active business operations and no country-level revenue reporting. Geographic exposure is therefore concentrated in U.S. corporate, legal, and reporting obligations.
Riskit
The company faces going-concern risk because it has no active operations and depends on continued related-party funding to pay public-company expenses. Its business model also carries execution risk: if management cannot find a suitable transaction or raise capital, the shell may remain inactive and delay any business plan. After a transaction, risks would shift to the acquired business, but today the main exposures are liquidity, sponsor dependence, and shell-company uncertainty.
The company has no active business operations and relies on external support to fund expenses.
Kohdistuu: Liquidity and survival of the shell entity
Cash flow needs are provided by a related party majority stockholder.
Kohdistuu: Global Funds support
The company’s stated purpose depends on finding and closing a transaction.
Kohdistuu: Strategic execution
Kirjanpito
Harkinnanvaraiset erätManagement states there is substantial doubt about the company’s ability to continue as a going concern.
Vaikutus: Affects disclosure, investor perception, and financing assumptions
Current results consist mainly of accounting and filing fees.
Vaikutus: Small absolute amounts can swing reported losses
A merger or acquisition would require purchase accounting and valuation judgments.
Vaikutus: Could materially affect assets, goodwill, and post-deal earnings
Samankaltaisia listattuja yhtiöitä
Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.
Greenland Mines Ltd
GRMLW · Biological Products, (No Diagnostic Substances)
Greenland Mines Ltd is a U.S.-based development-stage life sciences company that has not yet generated operating revenue.
Bio Green Med Solution, Inc.
BGMSP · Wholesale-Durable Goods, NEC
Public Co Management Corp
PCMC · Blank Checks
Public Co Management Corp is a U.S.-based shell company organized in Nevada.
Theglobe.com Inc
TGLO · Services-Advertising
Lucent, Inc.
LUCN · Services-Business Services, NEC
Generation Bio Co.
Pharmaceutical Preparations
Päivitetty: 28.4.2026